Casey Harrell's 3-Year BCI Record Sets a New Bar for Neurotech Timelines

8. Casey Harrell's 3-Year BCI Record Sets a New Bar for Neurotech Timelines

Casey Harrell, a man living with ALS-related paralysis, has logged thousands of hours using a brain-computer interface to produce speech since electrodes were embedded in his brain in 2023. The system, developed with a university research team, converts neural signals into spoken output. As of mid-2026, Harrell holds what MIT Technology Review describes as the most sustained real-world BCI usage record published to date, making him, in the team's own framing, "the first power user" of the technology.

That framing carries weight in a field where most published BCI results come from sessions measured in minutes or hours, not years. Neuralink, which received FDA Breakthrough Device designation in 2023 and implanted its first human subject in January 2024, has published limited longitudinal data. Synchron, whose Stentrode device reached human trials earlier, has shown multi-month results but nothing at this scale of cumulative use. Harrell's record does not belong to a commercial device, which means the competitive implication cuts both ways: it validates that long-term BCI operation is physiologically achievable, and it raises the bar that Neuralink and Synchron now need to clear to claim clinical durability in their own pipelines.

The broader pattern here is timeline compression. Two years ago, the standard skeptical position on BCIs was that long-term electrode stability and patient tolerance remained unproven. Harrell's data removes that objection, at least for one subject. The next data point worth watching is whether Neuralink's N1 implant cohort, now in expanded trials, produces comparable longitudinal records by end of 2026. If it does, BCI moves from a research curiosity to a category that insurance coverage discussions can no longer defer.

Source: MIT Technology Review